Pankti Reid to Neoplasms
This is a "connection" page, showing publications Pankti Reid has written about Neoplasms.
Connection Strength
1.547
-
Role-Specific Curricular Needs for Identification and Management of Immune-Related Adverse Events. J Cancer Educ. 2023 10; 38(5):1486-1492.
Score: 0.314
-
Treatment of rheumatic adverse events of cancer immunotherapy. Best Pract Res Clin Rheumatol. 2022 12; 36(4):101805.
Score: 0.308
-
Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy. J Clin Rheumatol. 2022 Oct 01; 28(7):367-373.
Score: 0.297
-
Immune Checkpoint Inhibitor Therapy Toxicities-Reply. JAMA. 2021 07 06; 326(1):87-88.
Score: 0.278
-
Management of Immunotherapy-Related Toxicities in Patients Treated With Immune Checkpoint Inhibitor Therapy. JAMA. 2021 Feb 02; 325(5):482-483.
Score: 0.270
-
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 11; 46(11):1049-1071.
Score: 0.080